Osteoclast-Derived Exosomal miR-5134-5p Interferes with Alveolar Bone Homeostasis by Targeting the JAK2/STAT3 Axis

References

• Henderson B, Kaiser F. Bacterial modulators of bone remodeling in the periodontal pocket. Periodontol. 2018;76(1):97–108. doi:10.1111/prd.12160
   Google Scholar
• Sims NA, Martin TJ. Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit. Bonekey Rep. 2014;3:481. doi:10.1038/bonekey.2013.215
   PubMedGoogle Scholar
• Hu CH, Sui BD, Liu J, et al. Sympathetic neurostress drives osteoblastic exosomal MiR-21 transfer to disrupt bone homeostasis and promote osteopenia. Small Methods. 2022;6(3):e2100763. doi:10.1002/smtd.202100763
   PubMed Web of Science ®Google Scholar
• Wang Q, Shen X, Chen Y, Chen J, Li Y. Osteoblasts-derived exosomes regulate osteoclast differentiation through miR-503-3p/Hpse axis. Acta Histochem. 2021;123(7):151790. doi:10.1016/j.acthis.2021.151790
   PubMed Web of Science ®Google Scholar
• Wang W, Qiao SC, Wu XB, et al. Circ_0008542 in osteoblast exosomes promotes osteoclast-induced bone resorption through m6A methylation. Cell Death Dis. 2021;12(7):628.
   PubMed Web of Science ®Google Scholar
• Aass KR, Nedal TMV, Tryggestad SS, et al. Paired miRNA-and messenger RNA-sequencing identifies novel miRNA-mRNA interactions in multiple myeloma. Sci Rep. 2022;12(1):12147.
   PubMed Web of Science ®Google Scholar
• Movassagh M, Morton SU, Hehnly C, et al. mirTarRnaSeq: an R/bioconductor statistical package for miRNA-mRNA target identification and interaction analysis. BMC Genom. 2022;23(1):439.
   PubMed Web of Science ®Google Scholar
• Leng Q, Chen L, Lv Y. RNA-based scaffolds for bone regeneration: application and mechanisms of mRNA, miRNA and siRNA. Theranostics. 2020;10(7):3190–3205.
   PubMed Web of Science ®Google Scholar
• Coutinho de Almeida R, Ramos YFM, Mahfouz A, et al. RNA sequencing data integration reveals an miRNA interactome of osteoarthritis cartilage. Ann Rheum Dis. 2019;78(2):270–277.
   PubMed Web of Science ®Google Scholar
• Jing W, Feng L, Peng K, Zhang W, Wang B. Formononetin attenuates osteoclast differentiation and calcium loss by mediating transcription factor AP-1 in type I diabetic mice. J Biochem Mol Toxicol. 2022;36(6):e23042. doi:10.1002/jbt.23042
   PubMed Web of Science ®Google Scholar
• Mousavi SM, Amin Mahdian SM, Ebrahimi MS, et al. Microfluidics for detection of exosomes and microRNAs in cancer: state of the art. Mol Ther Nucleic Acids. 2022;28:758–791. doi:10.1016/j.omtn.2022.04.011
   PubMedGoogle Scholar
• Ghaemmaghami AB, Mahjoubin-Tehran M, Movahedpour A, et al. Role of exosomes in malignant glioma: microRNAs and proteins in pathogenesis and diagnosis. Cell Commun Signal. 2020;18(1):120. doi:10.1186/s12964-020-00623-9
   PubMed Web of Science ®Google Scholar
• Lv PY, Gao PF, Tian GJ, et al. Osteocyte-derived exosomes induced by mechanical strain promote human periodontal ligament stem cell proliferation and osteogenic differentiation via the miR-181b-5p/PTEN/AKT signaling pathway. Stem Cell Res Ther. 2020;11(1):295. doi:10.1186/s13287-020-01815-3
   PubMed Web of Science ®Google Scholar
• Damerau A, Gaber T, Ohrndorf S, Hoff P. JAK/STAT activation: a general mechanism for bone development, homeostasis, and regeneration. Int J Mol Sci. 2020;21(23):9004. doi:10.3390/ijms21239004
   PubMed Web of Science ®Google Scholar
• Sanpaolo ER, Rotondo C, Cici D, Corrado A, Cantatore FP. JAK/STAT pathway and molecular mechanism in bone remodeling. Mol Biol Rep. 2020;47(11):9087–9096. doi:10.1007/s11033-020-05910-9
   PubMed Web of Science ®Google Scholar
• Liu B, Lu Y, Wang Y, Ge L, Zhai N, Han J. A protocol for isolation and identification and comparative characterization of primary osteoblasts from mouse and rat calvaria. Cell Tissue Bank. 2019;20(2):173–182. doi:10.1007/s10561-019-09751-0
   PubMed Web of Science ®Google Scholar
• MacArthur Clark JA, Sun D. Guidelines for the ethical review of laboratory animal welfare People’s Republic of China National Standard GB/T 35892-2018 [Issued 6 February 2018 Effective from 1 September 2018]. Anim Models Exp Med. 2020;3(1):103–113. doi:10.1002/ame2.12111
   PubMedGoogle Scholar
• Peng Y, Zhao M, Hu Y, et al. Blockade of exosome generation by GW4869 inhibits the education of M2 macrophages in prostate cancer. BMC Immunol. 2022;23(1):37. doi:10.1186/s12865-022-00514-3
   PubMed Web of Science ®Google Scholar
• Hajishengallis G, Korostoff JM. Revisiting the Page & Schroeder model: the good, the bad and the unknowns in the periodontal host response 40 years later. Periodontol. 2017;75(1):116–151.
   Google Scholar
• Li Y, Ling J, Jiang Q. Inflammasomes in alveolar bone loss. Front Immunol. 2021;12:691013. doi:10.3389/fimmu.2021.691013
   PubMed Web of Science ®Google Scholar
• Norouzi-Barough L, Shirian S, Gorji A, Sadeghi M. Therapeutic potential of mesenchymal stem cell-derived exosomes as a cell-free therapy approach for the treatment of skin, bone, and cartilage defects. Connect Tissue Res. 2022;63(2):83–96. doi:10.1080/03008207.2021.1887855
   PubMed Web of Science ®Google Scholar
• Yang JX, Xie P, Li YS, Wen T, Yang XC. Osteoclast-derived miR-23a-5p-containing exosomes inhibit osteogenic differentiation by regulating Runx2. Cell Signal. 2020;70:109504. doi:10.1016/j.cellsig.2019.109504
   PubMed Web of Science ®Google Scholar
• Cappariello A, Loftus A, Muraca M, Maurizi A, Rucci N, Teti A. Osteoblast-derived extracellular vesicles are biological tools for the delivery of active molecules to bone. J Bone Mineral Res. 2018;33(3):517–533. doi:10.1002/jbmr.3332
   PubMed Web of Science ®Google Scholar
• Morrell AE, Brown GN, Robinson ST, et al. Mechanically induced Ca(2+) oscillations in osteocytes release extracellular vesicles and enhance bone formation. Bone Res. 2018;6:6. doi:10.1038/s41413-018-0007-x
   PubMed Web of Science ®Google Scholar
• Hu H, Wang D, Li L, Yin H, He G, Zhang Y. Role of microRNA-335 carried by bone marrow mesenchymal stem cells-derived extracellular vesicles in bone fracture recovery. Cell Death Dis. 2021;12(2):156. doi:10.1038/s41419-021-03430-3
   PubMed Web of Science ®Google Scholar
• Sun W, Zhao C, Li Y, et al. Osteoclast-derived microRNA-containing exosomes selectively inhibit osteoblast activity. Cell Discov. 2016;2:16015. doi:10.1038/celldisc.2016.15
   PubMed Web of Science ®Google Scholar
• Xia X, Zhang L, Wu H, et al. CagA(+) helicobacter pylori, not CagA(-) Helicobacter pylori, infection impairs endothelial function through exosomes-mediated ROS formation. Front Cardiovasc Med. 2022;9:881372. doi:10.3389/fcvm.2022.881372
   PubMed Web of Science ®Google Scholar
• Wang H, Qi Y, Lan Z, et al. Exosomal PD-L1 confers chemoresistance and promotes tumorigenic properties in esophageal cancer cells via upregulating STAT3/miR-21. Gene Ther. 2023;30(1–2):88–100. doi:10.1038/s41434-022-00331-8
   PubMed Web of Science ®Google Scholar
• Mullen M, Williams K, LaRocca T, et al. Mechanical strain drives exosome production, function, and miRNA cargo in C2C12 muscle progenitor cells. J Orthopaed Res. 2023;41(6):1186–1197. doi:10.1002/jor.25467
   PubMed Web of Science ®Google Scholar
• Yao P, Lu Y, Cai Z, et al. Research progress of exosome-loaded miRNA in osteosarcoma. Cancer Control. 2022;29:10732748221076683. doi:10.1177/10732748221076683
   Web of Science ®Google Scholar
• Zeng ZL, Xie H. Mesenchymal stem cell-derived extracellular vesicles: a possible therapeutic strategy for orthopaedic diseases: a narrative review. Biomater Transl. 2022;3(3):175–187. doi:10.12336/biomatertransl.2022.03.002
   PubMedGoogle Scholar
• Li D, Liu J, Guo B, et al. Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation. Nat Commun. 2016;7:10872. doi:10.1038/ncomms10872
   PubMed Web of Science ®Google Scholar
• Hou X, Tian F. STAT3-mediated osteogenesis and osteoclastogenesis in osteoporosis. Cell Commun Signal. 2022;20(1):112. doi:10.1186/s12964-022-00924-1
   PubMed Web of Science ®Google Scholar
• Jo S, Wang SE, Lee YL, et al. IL-17A induces osteoblast differentiation by activating JAK2/STAT3 in ankylosing spondylitis. Arthritis Res Ther. 2018;20(1):115.
   PubMedGoogle Scholar
• Bharadwaj U, Kasembeli MM, Robinson P, Tweardy DJ. Targeting janus kinases and signal transducer and activator of transcription 3 to treat inflammation, fibrosis, and cancer: rationale, progress, and caution. Pharmacol Rev. 2020;72(2):486–526. doi:10.1124/pr.119.018440
   PubMed Web of Science ®Google Scholar
• Johnson DE, O’Keefe RA, Grandis JR. Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat Rev. 2018;15(4):234–248. doi:10.1038/nrclinonc.2018.8
   Google Scholar
• Li J, Yin Z, Huang B, Xu K, Su J. Stat3 signaling pathway: a future therapeutic target for bone-related diseases. Front Pharmacol. 2022;13:897539. doi:10.3389/fphar.2022.897539
   PubMed Web of Science ®Google Scholar
• Ziros PG, Georgakopoulos T, Habeos I, Basdra EK, Papavassiliou AG. Growth hormone attenuates the transcriptional activity of Runx2 by facilitating its physical association with Stat3beta. J Bone Mineral Res. 2004;19(11):1892–1904. doi:10.1359/JBMR.040701
   PubMed Web of Science ®Google Scholar
• Yu X, Li Z, Wan Q, et al. Inhibition of JAK2/STAT3 signaling suppresses bone marrow stromal cells proliferation and osteogenic differentiation, and impairs bone defect healing. Biol Chem. 2018;399(11):1313–1323. doi:10.1515/hsz-2018-0253
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang L, Wang K, et al. Circulating exosomes from mice with LPS-induced bone loss inhibit osteoblast differentiation. Calcif Tissue Int. 2022;111(2):185–195. doi:10.1007/s00223-022-00977-x
   PubMed Web of Science ®Google Scholar
• Huang X, Xie M, Xie Y, et al. The roles of osteocytes in alveolar bone destruction in periodontitis. J Transl Med. 2020;18(1):479. doi:10.1186/s12967-020-02664-7
   PubMed Web of Science ®Google Scholar
• Guo H, Huang X. Engineered exosomes for future gene-editing therapy. Biomater Transl. 2022;3(4):240–242. doi:10.12336/biomatertransl.2022.04.003
   PubMedGoogle Scholar
• Zhou D, Zhou F, Sheng S, Wei Y, Chen X, Su J. Intra-articular nanodrug delivery strategies for treating osteoarthritis. Drug Discov Today. 2023;28(3):103482. doi:10.1016/j.drudis.2022.103482
   PubMed Web of Science ®Google Scholar
• Guo J, Wang F, Hu Y, et al. Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases. Cell Rep Med. 2023;4(1):100881. doi:10.1016/j.xcrm.2022.100881
   PubMedGoogle Scholar